CUPE - Fall 2026 - TA - PBH5107

Posting Reason

New Position

Location where work is to be performed

Smyth, Alta Vista, General Hospital, CHEO Campuses

Session

2026 Fall Semester | Trimestre d'automne

Faculty

Faculté de médecine/ Faculty of Medicine

Unit

Faculty Payroll - Students and Casuals

Job Classification

Teaching Assistant/Demonstrator/Lab Monitor (CUPE)

Posting Type

Cours précis / Specific course

Course Title

Biostatistics for Public Health

Course Code

PBH5107

Section

Supervisor name (if known)

Dr. Tim Ramsay

Date Posted (YYYY/MM/DD)

2026/07/13

Applications must be received BEFORE (YYYY/MM/DD)

2026/08/04

Description of tasks (hours)

Unless specified below, specific allocation of hours to various tasks should be articulated in a description of work negotiated and signed by you and the supervising professor prior to the commencement of work.

Recherche / Research:0

Préparation / Preparation:60

Contact avec étudiants / Contact with Students:36

Correction - Notation / Grading:25

Surveillance / Proctoring:9

Formation / Training:0

Autre / Other:0

Number of positions

1

Expected Enrolment

60

Work Start Date

September 08, 2026

Work End Date

December 18, 2026

Total Work Hours

80

Hourly Rate

• AE-RA-Tuteur / TA-RA-Tutor : $31.89 ou/or $50.25 (2024-2025)
• The academic year starts on September 1 and ends on August 31.
• Undergraduate students will be paid at the lower rate; while graduate students will be paid at the higher rate.
• These rates do not included vacation pay nor statutory pay.
• These rates will be applied until a new collective agreement is ratified. Retro will be paid after the ratification.

Language of Work

Anglais | English

Requirements and Nature of Work

Nature of Work

• Leading discussion groups and lab activities
• Reviewing material
• Helping to develop and review tutorial and exam questions
• Helping to manage Brightspace discussion forum
• Grading 1-2 final exam short-answer questions

Requirements

• Must be able to use statistical software to manage data and perform descriptive analysis, parameter estimation and hypothesis testing as well as nonparametric tests, power calculation and regression modeling.
• Advanced critical appraisal skills.
• Must have completed a graduate level course in Biostatistics.
• Previous completion of EPI 5242 or PBH 5107 within the past 2 years with a high average is considered an asset.

Additional Information and/or Comments

All University of Ottawa employees are required under provincial law to successfully complete all mandatory legislated training offered by the University. The list of training requirements may be modified by provincial law. If you are invited to continue the selection process, please notify us of any particular adaptive measures you might require. We may consult with the Health and Wellness sector of Human Resources, if needed. Any information you send us will be handled respectfully and in complete confidence.

The hiring process will be governed by the current CUPE 2626 collective agreement; you can click here to find out more.

The University of Ottawa embraces diversity and inclusion in the workplace. We are passionate about our people and committed to employment equity. We foster a culture of respect, teamwork and inclusion, where collaboration, innovation, and creativity fuel our quest for research and teaching excellence. While all qualified persons are invited to apply, we welcome applications from qualified Indigenous persons, racialized persons, persons with disabilities, women and LGBTQIA2S+ persons. The University is committed to creating and maintaining an accessible, barrier-free work environment. The University is also committed to working with applicants with disabilities requesting accommodation during the recruitment, assessment and selection processes. Applicants with disabilities may contact the academic unit to communicate the accommodation need.

Prior to May 1, 2022, the University required all students, faculty, staff, and visitors (including contractors) to be fully vaccinated against Covid-19 as defined in Policy 129 – Covid-19 Vaccination. This policy was suspended effective May 1, 2022 but may be reinstated at any point in the future depending on public health guidelines and the recommendations of experts.